Sensei Biotherapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
SNSE on Nasdaq
Industry
Pharmaceutical Preparations
Location
1405 Research Blvd, Suite 125, Rockville, MD

There are no Buy or Sell transactions made by insiders since 12/8/2024

Sensei Biotherapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert Hamilton Pierce Chief R&D Officer $80.3K Feb 15, 2022
Erin Colgan Chief Financial Officer $53.3K Feb 15, 2024
John Celebi PRESIDENT AND CEO, Director $50.4K Feb 19, 2025
Patrick Stephen Gallagher Chief Business Officer $29K Feb 15, 2023
Edward van der Horst Chief Scientific Officer $28.5K Feb 19, 2025
Christopher Gerry President & PEO $15.2K Nov 14, 2025
Jessie English Director $7.59K Jun 11, 2024
Deneen Vojta Director $7.59K Jun 11, 2024
Samuel Broder Director $7.59K Jul 10, 2023
Stephanie Krebs Chief Business Officer Feb 14, 2025
Thomas G. Ricks Director May 21, 2025
David Gaiero Principal Financial Officer May 10, 2024
Josiah Craver Principal Financial Officer Feb 14, 2025
Cambrian BioPharma Inc 10%+ Owner May 21, 2025
Bob Holmen Director May 21, 2025
James Peyer Director, 10%+ Owner May 21, 2025
William R. Ringo Director May 21, 2025
Kristian Humer Director May 21, 2025
Apeiron Investment Group Ltd. 10%+ Owner Jun 1, 2023

Recent Insider Transactions by Companies or Individuals for Sensei Biotherapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.